RE:RE:NoticeAgree, 745k land sale is the tip of the iceberg, conservatively, 10m for the actual facility, that's 100m share buyback at 10c, increasing everyone's ownership percentage by 25% including insiders who collectively own 19.56%....MPLs market cap is only around 35m and breakeven/profitability is around the corner. 8 consecutive quarters of ebita improvement ...yes the share price is terrible however the company is outperforming 98% in cash burn/ ebita/ gross margin...it's interesting despite it being printed in the MD&A, spoken on the CC we still have denyiers on the fact MPL has partners/Clients with new and novel drug applications sitting in the FDA...MPL is killing it...share price isn't following..